Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T13:45:19.627Z.
Calculation as of: 2026-10-06T13:45:19.627Z.
Quote observation: 2026-10-06T13:45:11.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 3dded1d9c7c97f6604bba9f83d6a77d690042e17e53b2ba4f54e500de5eb4a7b
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
Market Cap
$278.05M
EV/FCF Ratio
N/A
TTM Avg
1.69x
3Y Avg
1.69x
5Y Avg
1.69x
Market Cap
$281.92M
EV/FCF Ratio
N/A
TTM Avg
52.46x
3Y Avg
52.46x
5Y Avg
52.46x
Market Cap
$289.27M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$290.11M
EV/FCF Ratio
N/A
TTM Avg
37.98x
3Y Avg
37.98x
5Y Avg
37.98x
Market Cap
$264.62M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aurora Cannabis Inc. (ACB) | $277.81M | N/A | N/A | N/A | N/A |
| Indaptus Therapeutics, Inc. (INDP)vs › | $278.05M | N/A | 1.69x | 1.69x | 1.69x |
| Fate Therapeutics, Inc. (FATE)vs › | $281.49M | N/A | N/A | N/A | N/A |
| Fulcrum Therapeutics, Inc. (FULC)vs › | $281.92M | N/A | 52.46x | 52.46x | 52.46x |
| AC Immune S.A. (ACIU)vs › | $274.28M | N/A | 4.58x | 4.76x | 4.76x |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $289.27M | N/A | N/A | N/A | N/A |
| Abeona Therapeutics Inc. (ABEO)vs › | $290.11M | N/A | 37.98x | 37.98x | 37.98x |
| Larimar Therapeutics, Inc. (LRMR)vs › | $290.35M | N/A | N/A | N/A | N/A |
| Lexeo Therapeutics, Inc. Common Stock (LXEO)vs › | $264.62M | N/A | N/A | N/A | N/A |
| Century Therapeutics, Inc. (IPSC)vs › | $264.37M | N/A | N/A | N/A | N/A |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
